You searched for: Prolight
Prolight's CSO reflects on positive pre-clinical results and looks ahead to key milestones in Q2
Prolight Diagnostics has taken an important step forward with its Psyros point-of-care (POC) diagnostic platform. A recent pre-clinical study...
Prolight Diagnostics comments on acquisition of competitor
Prolight Diagnostics' Norwegian competitor SpinChip Diagnostics was recently acquired by bioMérieux for EUR 138 million, which constitutes one of the largest...
Prolight sees business opportunity for plasma separation technology
Prolight Diagnostics has secured a patent in the EU for a separation technology used in the MicroFlex system to separate plasma from...
Prolight's COO: "Pilot line paves the way for scalability"
Prolight Diagnostics recently conducted a business review of the pilot production line at its partner, FlexMedical Solutions. The production line will deliver test cards to...
Patient-centered analyses in focus at Cardiac Markers Dialogue Meeting
Prolight Diagnostics recently participated in the 2024 Cardiac Markers Dialogue Meeting in Glasgow. The meeting brought together leading researchers and healthcare professionals...
Investing in life science: From Seed to Success 2024
Last week, investors and entrepreneurs gathered at the World Trade Center in Stockholm for "Investing in Life Science: From Seed...
Prolight Diagnostics advances towards validation of tests for heart attack diagnostics
Prolight Diagnostics' second quarter report reports significant progress in the development of the patient-facing analysis system Psyros. Not least, it received...
Prolight Diagnostics receives positive feedback at ADLM Congress
Prolight Diagnostics recently participated at the ADLM congress in Chicago, where the company had the opportunity to present its...
Prolight's partner TTP provides an update on MicroFlex
Prolight Diagnostics and TTP have developed the MicroFlex Point-of-Care system, with the goal of being able to perform diagnostic tests closer to the patient. The system enables...
BioStock Global Forum 2024
On May 29-30, BioStock hosted the Global Forum. The event is the first of its kind, aimed at bringing...
Prolights Diagnostics CEO: "We continue to deliver what we promise"
Prolight Diagnostics CEO Ulf Bladin visited BioStock's studio to demonstrate the company's patient-facing troponin test to detect or rule out...
Prolight Diagnostics strengthens the board with experienced business developer
Prolight Diagnostics expands its board of directors with Kiarash Farr, who has extensive experience in sales, business development and diagnostics.